Skip to content

NRF releases statement supporting federal legislation to combat retail crime

“We urge Congress to move quickly to approve this integral measure.”

Photo by Obi - @pixel9propics / Unsplash

WASHINGTON – The Executive Vice President of Government Relations for the National Retail Federation, David French, has issued a statement following the introduction of the Combating Organized Retail Crime Act of 2025 by Senate Judiciary Committee Chairman Chuck Grassley, R-Iowa, Senator Catherine Cortez Masto, D-Nev., and Representative Dave Joyce, R-Ohio.

NRF’s report titled “The Impact of Retail Theft & Violence 2024” reveals that approximately 73% of respondents believe shoplifters are demonstrating increased violence and aggression compared to last year. Additionally, nearly all retailers (94%) consider federal legislation essential for effectively addressing this problem.

Statement of Executive Vice President of Government Relations for the National Retail Federation, David French:

“ORC is a multibillion-dollar crisis impacting retailers, their associates and the customers they serve. ORC is occurring across the retail enterprise – supply chains, bricks-and-mortar stores, warehouses and online – with stolen product sold for a profit, oftentimes to fund other crimes.

“The Combating Organized Retail Crime Act of 2025 will align efforts within a new Organized Retail and Supply Chain Crime Coordination Center to ensure that resources and information-sharing will be available across local, state, federal and private-sector partners to bring cases and prosecutions against organized theft groups. This legislation is an important step to help prevent ORC from infiltrating local communities across the country.

“NRF applauds Chairman Grassley, Sen. Cortez Masto, Rep. Joyce and all of their bipartisan original co-sponsors for their continued leadership to address one of retail’s biggest challenges. We urge Congress to move quickly to approve this integral measure.”

Comments

Latest

AAM issues comments on Section 232 investigation on pharmaceuticals

AAM issues comments on Section 232 investigation on pharmaceuticals

“AAM and the generics and biosimilars industry look forward to working with the Commerce Department and the White House to engage constructively on ways to incent more domestic investment in the medicines supply chain,” said John Murphy III, president and CEO.